EndoGastric® Solutions Announces Further Expansion of Medicare Reimbursement for Transoral Incisionless Fundoplication (TIF®) 2.0 Procedure »
November 14, 2017
Expanded Medicare coverage and update to facility reimbursement increases patient access to non-surgical alternative for long-term control of acid reflux symptoms REDMOND, Wash. (November 14, 2017) – Medicare beneficiaries in 23 additional states have been granted reimbursed access to the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure following positive coverage decisions by Medicare Administrative Contractors (MACs) […] More »
EndoGastric® Solutions Announces Expanded Medicare Reimbursement for Transoral Incisionless Fundoplication (TIF®) Procedure »
October 26, 2017
Effective alternative for long-term control of acid reflux symptoms will now be available to over 60% of Medicare patients REDMOND, Wash. – Medicare beneficiaries in 10 Midwestern and Northeastern states will soon have reimbursed access to the Transoral Incisionless Fundoplication (TIF®) procedure following a decision by Medicare Administrative Contractor (MAC) National Government Services, Inc. (NGS). […] More »
EndoGastric Solutions Announces 12-month Data Validating Hiatal Hernia Repair Prior to Transoral Incisionless Fundoplication (TIF®) as a Durable GERD Treatment Option »
October 16, 2017
Study participants saw 80 percent improvement for heartburn and regurgitation one-year post procedure when hiatal hernia and gastroesophageal valve were repaired sequentially REDMOND, Wash. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the presentation of data from the Transoral Incisionless Fundoplication (TIF ®) 2.0 procedure using […] More »
EndoGastric Solutions Announces the Presentation of 4 Year TEMPO Data Confirming Long-term Control of Chronic GERD Symptoms with TIF procedure »
September 6, 2017
Longest follow-up data from randomized controlled trial classifies the TIF procedure as a durable alternative to medications and traditional anti-reflux surgery REDMOND, Wash. – EndoGastric® Solutions (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the presentation of four-year follow-up data from TEMPO (TIF® EsophyX vs Medical PPI Open Label), a […] More »
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 16
- Next Page »